Go sign green light
Biotech

FDA reconsidering Capricor’s snubbed DMD cell therapy

The agency has “lifted” the rejection letter for deramiocel, the company said, with a new decision expected by Aug. 22.
Darren Incorvaia Mar 10, 2026 11:14am
Ugur Sahin

BioNTech's CEO, CMO will depart to set up next-gen mRNA company

Mar 10, 2026 6:30am
How physiology powers biotech innovation

How physiology powers biotech innovation

Brought to you by American Physiological Society
The Capitol Building in Washington DC with bright blue sky - stock photo Becky WrightGetty Images

‘Bureaucratic idiocy’: GOP senator to investigate FDA rejections

Mar 10, 2026 11:10am
An abstract image of data

ARPA-H kicks off wearable biosensor development program

Mar 10, 2026 1:59pm
no longer in business sign

Molecular glue biotech f5 Therapeutics closes down

Mar 10, 2026 1:10pm
More News

Lilly pledges $500M to South Korea biopharma industry

Mar 10, 2026 12:00pm

Fierce Biotech Layoff Tracker 2026: f5 Tx, Vertex & more

Mar 10, 2026 11:00am

Medtronic to drop $550M for Scientia and its stroke care catalog

Mar 10, 2026 10:34am

Voyager pauses Alzheimer's program 8 months after unveiling med

Mar 10, 2026 10:20am